Oramed

Oramed Pharmaceuticals (NASDAQCM:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes. Read more:

pharmaceuticals
10-50 employees
Jerusalem, Israel
Founded 2006

About Oramed

Oramed Pharmaceuticals (NASDAQCM:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes. Read more:

Company Details

Business Type public-company
Revenue $1M-$10M
Website oramed.com

Social Media

Technologies

elementor google-analytics google-tag-manager microsoft-365 nginx php vue-js wordpress

Frequently Asked Questions

What does Oramed do?

Oramed Pharmaceuticals (NASDAQCM:ORMP) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 trials under the USFDA, the Company is seeking to revolutionize the treatment of diabetes. Read more:

How can I contact Oramed?

Visit their website at oramed.com for more information.

Where is Oramed located?

Jerusalem, Israel

What industry is Oramed in?

pharmaceuticals

How many employees does Oramed have?

10-50

When was Oramed founded?

2006

Looking for More Company Information?

Discover more innovative companies in our comprehensive directory.

Browse All Companies